Detalhe da pesquisa
1.
Genome-wide CRISPR screen identifies CDK6 as a therapeutic target in adult T-cell leukemia/lymphoma.
Blood
; 139(10): 1541-1556, 2022 03 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34818414
2.
Effective Cytotoxicity of Dendritic Cells against Established T Cell Lymphomas in Mice.
J Immunol
; 207(4): 1194-1199, 2021 08 15.
Artigo
Inglês
| MEDLINE | ID: mdl-34330751
3.
IL-15 enhanced antibody-dependent cellular cytotoxicity mediated by NK cells and macrophages.
Proc Natl Acad Sci U S A
; 115(46): E10915-E10924, 2018 11 13.
Artigo
Inglês
| MEDLINE | ID: mdl-30373815
4.
Engagement of lymphoma T cell receptors causes accelerated growth and the secretion of an NK cell-inhibitory factor.
Cell Immunol
; 357: 104213, 2020 11.
Artigo
Inglês
| MEDLINE | ID: mdl-32977157
5.
NK cells prevent T cell lymphoma development in T cell receptor-transgenic mice.
Cell Immunol
; 352: 104081, 2020 06.
Artigo
Inglês
| MEDLINE | ID: mdl-32143838
6.
Selective dependence of H2-M3-restricted CD8 responses on IL-15.
J Immunol
; 188(6): 2575-82, 2012 Mar 15.
Artigo
Inglês
| MEDLINE | ID: mdl-22312130
7.
Paracrine and transpresentation functions of IL-15 are mediated by diverse splice versions of IL-15Rα in human monocytes and dendritic cells.
J Biol Chem
; 287(48): 40328-38, 2012 Nov 23.
Artigo
Inglês
| MEDLINE | ID: mdl-23074221
8.
Interleukin-15 augments NK cell-mediated ADCC of alemtuzumab in patients with CD52+ T-cell malignancies.
Blood Adv
; 7(3): 384-394, 2023 02 14.
Artigo
Inglês
| MEDLINE | ID: mdl-35475910
9.
Interleukin-15 combined with an anti-CD40 antibody provides enhanced therapeutic efficacy for murine models of colon cancer.
Proc Natl Acad Sci U S A
; 106(18): 7513-8, 2009 May 05.
Artigo
Inglês
| MEDLINE | ID: mdl-19383782
10.
A very long-acting IL-15: implications for the immunotherapy of cancer.
J Immunother Cancer
; 10(1)2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35101947
11.
Short-course IL-15 given as a continuous infusion led to a massive expansion of effective NK cells: implications for combination therapy with antitumor antibodies.
J Immunother Cancer
; 9(4)2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33883258
12.
IL-15 in the Combination Immunotherapy of Cancer.
Front Immunol
; 11: 868, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-32508818
13.
A phase 1 study of interleukin-15 in combination with avelumab in relapsed or refractory T-cell lymphoma.
Leuk Lymphoma
; : 1-4, 2024 Mar 09.
Artigo
Inglês
| MEDLINE | ID: mdl-38459780
14.
IL-2 and IL-15 blockade by BNZ-1, an inhibitor of selective γ-chain cytokines, decreases leukemic T-cell viability.
Leukemia
; 33(5): 1243-1255, 2019 05.
Artigo
Inglês
| MEDLINE | ID: mdl-30353031
15.
IL15 by Continuous Intravenous Infusion to Adult Patients with Solid Tumors in a Phase I Trial Induced Dramatic NK-Cell Subset Expansion.
Clin Cancer Res
; 25(16): 4945-4954, 2019 08 15.
Artigo
Inglês
| MEDLINE | ID: mdl-31142503
16.
Targeting the HTLV-I-Regulated BATF3/IRF4 Transcriptional Network in Adult T Cell Leukemia/Lymphoma.
Cancer Cell
; 34(2): 286-297.e10, 2018 08 13.
Artigo
Inglês
| MEDLINE | ID: mdl-30057145
17.
IL15 Infusion of Cancer Patients Expands the Subpopulation of Cytotoxic CD56bright NK Cells and Increases NK-Cell Cytokine Release Capabilities.
Cancer Immunol Res
; 5(10): 929-938, 2017 10.
Artigo
Inglês
| MEDLINE | ID: mdl-28842470
18.
Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells, and cytokine production during first-in-human clinical trial of recombinant human interleukin-15 in patients with cancer.
J Clin Oncol
; 33(1): 74-82, 2015 Jan 01.
Artigo
Inglês
| MEDLINE | ID: mdl-25403209
19.
Loss of cytotoxicity and gain of cytokine production in murine tumor-activated NK cells.
PLoS One
; 9(8): e102793, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-25101668
20.
Preassociation of IL-15 with IL-15R alpha-IgG1-Fc enhances its activity on proliferation of NK and CD8+/CD44high T cells and its antitumor action.
J Immunol
; 180(4): 2099-106, 2008 Feb 15.
Artigo
Inglês
| MEDLINE | ID: mdl-18250415